id	sid	eid	entity	type
fnp-5269	1	1	5:18	DATE
fnp-5269	1	2	2024	CARDINAL
fnp-5269	1	3	samir alsalek1*	PERSON
fnp-5269	2	1	alexander s. himstead2,3*	PERSON
fnp-5269	2	2	self2	PERSON
fnp-5269	2	3	gianna m. fote2	PERSON
fnp-5269	2	4	vadera2	DATE
fnp-5269	2	5	edwin s. monuki3	PERSON
fnp-5269	2	6	mari perez-rosendahl3	PERSON
fnp-5269	3	1	william h. yong3	PERSON
fnp-5269	3	2	bernard j. tyson	PERSON
fnp-5269	3	3	98	CARDINAL
fnp-5269	3	4	los robles ave	GPE
fnp-5269	3	5	pasadena	GPE
fnp-5269	3	6	91101	DATE
fnp-5269	3	7	university of california	ORG
fnp-5269	3	8	irvine	GPE
fnp-5269	3	9	200	CARDINAL
fnp-5269	3	10	manchester ave	PERSON
fnp-5269	3	11	210	CARDINAL
fnp-5269	3	12	92868	DATE
fnp-5269	3	13	university of california	ORG
fnp-5269	3	14	irvine	GPE
fnp-5269	3	15	101	CARDINAL
fnp-5269	3	16	92868	DATE
fnp-5269	3	17	william yong ·	PERSON
fnp-5269	3	18	uc irvine health	ORG
fnp-5269	3	19	101	CARDINAL
fnp-5269	3	20	92868	DATE
fnp-5269	3	21	usa yongwh@hs.uci.edu	PERSON
fnp-5269	3	22	03 february 2024	DATE
fnp-5269	3	23	13	CARDINAL
fnp-5269	3	24	félicia jeannelle	PERSON
fnp-5269	3	25	21	CARDINAL
fnp-5269	3	26	2024	CARDINAL
fnp-5269	3	27	https://doi.org/10.17879/freeneuropathology-2024-5269	PRODUCT
fnp-5269	3	28	cd34	PRODUCT
fnp-5269	3	29	mtle	PERSON
fnp-5269	3	30	mtle	PERSON
fnp-5269	4	1	mtle	PERSON
fnp-5269	5	1	mtle-hs	PERSON
fnp-5269	6	1	31-year-old	DATE
fnp-5269	10	1	less than	CARDINAL
fnp-5269	11	1	2 years	DATE
fnp-5269	14	1	mtle-hs	PERSON
fnp-5269	15	1	almost half	CARDINAL
fnp-5269	17	1	gtc	ORG
fnp-5269	17	2	ihc immunohistochemistry	ORG
fnp-5269	17	3	ilae international league	ORG
fnp-5269	17	4	ipi	ORG
fnp-5269	17	5	mtle	PERSON
fnp-5269	18	1	mtle	PERSON
fnp-5269	18	2	treatment.1–3	PERSON
fnp-5269	18	3	mtle	PERSON
fnp-5269	18	4	ipi	ORG
fnp-5269	18	5	2013	DATE
fnp-5269	18	6	1	CARDINAL
fnp-5269	18	7	1	CARDINAL
fnp-5269	18	8	4	CARDINAL
fnp-5269	18	9	2	CARDINAL
fnp-5269	18	10	ca1	CARDINAL
fnp-5269	18	11	3	CARDINAL
fnp-5269	18	12	fourth	ORDINAL
fnp-5269	18	13	loss.8 immunohistochemistry	ORG
fnp-5269	18	14	ihc	ORG
fnp-5269	20	1	ihc	ORG
fnp-5269	20	2	mtle	PERSON
fnp-5269	20	3	mtle-hs	PERSON
fnp-5269	21	1	mtle	PERSON
fnp-5269	22	1	31-year-old	DATE
fnp-5269	22	2	five-year	DATE
fnp-5269	27	1	1	CARDINAL
fnp-5269	28	1	two	CARDINAL
fnp-5269	29	1	wada	ORG
fnp-5269	31	1	postoperative day 1	DATE
fnp-5269	32	1	11 months	DATE
fnp-5269	33	1	two years	DATE
fnp-5269	33	2	engel	GPE
fnp-5269	33	3	1	CARDINAL
fnp-5269	34	1	1	CARDINAL
fnp-5269	37	1	ca1	PRODUCT
fnp-5269	37	2	1	CARDINAL
fnp-5269	37	3	2a	CARDINAL
fnp-5269	40	1	ca1	PRODUCT
fnp-5269	40	2	2b	CARDINAL
fnp-5269	41	1	less than	CARDINAL
fnp-5269	42	1	ca2	GPE
fnp-5269	42	2	2d	DATE
fnp-5269	44	1	2e	CARDINAL
fnp-5269	45	1	2	CARDINAL
fnp-5269	48	1	2h	CARDINAL
fnp-5269	49	1	2	CARDINAL
fnp-5269	49	2	2i	CARDINAL
fnp-5269	50	1	2j	CARDINAL
fnp-5269	51	1	less than	CARDINAL
fnp-5269	52	1	2	CARDINAL
fnp-5269	53	1	2n	CARDINAL
fnp-5269	54	1	synaptophysin	PERSON
fnp-5269	56	1	idh1	ORG
fnp-5269	56	2	r132h	PERSON
fnp-5269	56	3	immunostain	PERSON
fnp-5269	57	1	two	CARDINAL
fnp-5269	58	1	48.5 %	PERCENT
fnp-5269	59	1	less than	CARDINAL
fnp-5269	59	2	20–40 %	PERCENT
fnp-5269	59	3	∼5 %	GPE
fnp-5269	61	1	2	CARDINAL
fnp-5269	62	1	a. neun	PERSON
fnp-5269	62	2	ca1	PRODUCT
fnp-5269	63	1	20x	CARDINAL
fnp-5269	64	1	ca1	PRODUCT
fnp-5269	65	1	200x	PRODUCT
fnp-5269	66	1	c. neun	PERSON
fnp-5269	66	2	ca1	ORG
fnp-5269	72	1	400x	PRODUCT
fnp-5269	73	1	f. two	PERSON
fnp-5269	74	1	asterisk	ORG
fnp-5269	75	1	400x	PRODUCT
fnp-5269	81	1	i.	PERSON
fnp-5269	83	1	asterisk	ORG
fnp-5269	84	1	j. aggregates	PERSON
fnp-5269	86	1	asterisk	ORG
fnp-5269	89	1	400x	CARDINAL
fnp-5269	90	1	m. gfap	PERSON
fnp-5269	92	1	n. neurofilament	PERSON
fnp-5269	93	1	400x	CARDINAL
fnp-5269	94	1	mtle-hs	PERSON
fnp-5269	95	1	mtle-hs	PERSON
fnp-5269	95	2	ipi	ORG
fnp-5269	96	1	1 hs	PERSON
fnp-5269	96	2	the age of 5	DATE
fnp-5269	97	1	ca1	ORG
fnp-5269	97	2	2	CARDINAL
fnp-5269	97	3	ca1	ORG
fnp-5269	98	1	2	CARDINAL
fnp-5269	98	2	213	CARDINAL
fnp-5269	98	3	2	CARDINAL
fnp-5269	98	4	hs	PERSON
fnp-5269	98	5	greater than	CARDINAL
fnp-5269	98	6	80 %	PERCENT
fnp-5269	98	7	engel	PERSON
fnp-5269	99	1	2	CARDINAL
fnp-5269	99	2	engel	PERSON
fnp-5269	99	3	ia	GPE
fnp-5269	99	4	1 hs patients.16	QUANTITY
fnp-5269	99	5	389	CARDINAL
fnp-5269	99	6	247	CARDINAL
fnp-5269	99	7	engel	PERSON
fnp-5269	99	8	ia	GPE
fnp-5269	100	1	cd34	PRODUCT
fnp-5269	100	2	function,20	DATE
fnp-5269	100	3	mtle-hs.6 cd34	LAW
fnp-5269	100	4	187	CARDINAL
fnp-5269	100	5	up to half	CARDINAL
fnp-5269	101	1	89 %	PERCENT
fnp-5269	101	2	engel class ii	ORG
fnp-5269	101	3	cd34	PRODUCT
fnp-5269	102	1	calderon-garciduenas	ORG
fnp-5269	102	2	al.6	ORG
fnp-5269	102	3	cd34	PRODUCT
fnp-5269	102	4	mtle	PERSON
fnp-5269	103	1	17 %	PERCENT
fnp-5269	103	2	40/236	CARDINAL
fnp-5269	103	3	mtle	PERSON
fnp-5269	105	1	cd34	PRODUCT
fnp-5269	106	1	2 hs	QUANTITY
fnp-5269	106	2	non-hs	PERSON
fnp-5269	106	3	non-hs	PERSON
fnp-5269	108	1	1	CARDINAL
fnp-5269	108	2	mtle-hs	PERSON
fnp-5269	109	1	2 years	DATE
fnp-5269	112	1	mtle-hs.6	ORG
fnp-5269	112	2	sequencing.26	ORG
fnp-5269	113	1	almost half	CARDINAL
fnp-5269	116	1	less than	CARDINAL
fnp-5269	117	1	600	CARDINAL
fnp-5269	117	2	dysplasia,20,23	PERSON
fnp-5269	117	3	about 17 %	PERCENT
fnp-5269	118	1	calderon-garciduenas et al	ORG
fnp-5269	118	2	5	CARDINAL
fnp-5269	118	3	236	CARDINAL
fnp-5269	118	4	2 %	PERCENT
fnp-5269	118	5	mtle-hs	PERSON
fnp-5269	118	6	three	CARDINAL
fnp-5269	118	7	2	CARDINAL
fnp-5269	119	1	5	CARDINAL
fnp-5269	119	2	braf+ hs	PERSON
fnp-5269	121	1	28	CARDINAL
fnp-5269	122	1	20 %	PERCENT
fnp-5269	122	2	25	CARDINAL
fnp-5269	123	1	lerond et al.9	ORG
fnp-5269	124	1	2018	DATE
fnp-5269	124	2	koh	PERSON
fnp-5269	125	1	20	CARDINAL
fnp-5269	125	2	1	CARDINAL
fnp-5269	125	3	mtle-hs	PERSON
fnp-5269	126	1	vemurafenib	PERSON
fnp-5269	127	1	koh	PERSON
fnp-5269	130	1	mtle	PERSON
fnp-5269	140	1	1	CARDINAL
fnp-5269	140	2	mtle-hs	PERSON
fnp-5269	147	1	only approximately 2 %	CARDINAL
fnp-5269	147	2	mtle-hs	PERSON
fnp-5269	148	1	mtle	PERSON
fnp-5269	148	2	mtle-hs	PERSON
fnp-5269	149	1	jefferson chan	PERSON
fnp-5269	149	2	uc irvine	ORG
fnp-5269	152	1	1	CARDINAL
fnp-5269	154	1	opin pharmacother	PERSON
fnp-5269	155	1	2015;16(15):2355-2371	DATE
fnp-5269	157	1	berg	PERSON
fnp-5269	159	1	curr opin	PERSON
fnp-5269	159	2	neurol	GPE
fnp-5269	160	1	2008;21(2):173	CARDINAL
fnp-5269	162	1	3	CARDINAL
fnp-5269	162	2	semah	PERSON
fnp-5269	162	3	demeret s.	PERSON
fnp-5269	163	1	neurol	GPE
fnp-5269	164	1	2002;59(6):1042-1043	CARDINAL
fnp-5269	164	2	1043	CARDINAL
fnp-5269	165	1	https://doi.org/10.1001/archneur.59.6.1042-a	PERSON
fnp-5269	166	1	malmgren k	PERSON
fnp-5269	166	2	thom m. hippocampal sclerosis	PERSON
fnp-5269	168	1	2012;53	CARDINAL
fnp-5269	168	2	4:19-33	DATE
fnp-5269	170	1	5	CARDINAL
fnp-5269	170	2	varoglu ao	PERSON
fnp-5269	170	3	saygi s	ORG
fnp-5269	170	4	acemoglu h	ORG
fnp-5269	170	5	ciger a. prognosis	PERSON
fnp-5269	172	1	2009;85(2-3):206	CARDINAL
fnp-5269	174	1	calderon-garcidueñas al	PERSON
fnp-5269	174	2	lévy p	PERSON
fnp-5269	178	1	https://doi.org/10.1111/bpa.12596.	DATE
fnp-5269	179	1	pauli e	PERSON
fnp-5269	179	2	clusmann h	ORG
fnp-5269	182	1	2007;113(3):235-244	CARDINAL
fnp-5269	184	1	8	CARDINAL
fnp-5269	186	1	the ilae commission	ORG
fnp-5269	188	1	2013;54(7):1315-1329	DATE
fnp-5269	191	1	lerond j	PERSON
fnp-5269	191	2	scopin m	PERSON
fnp-5269	193	1	2023;49(5):e12937	DATE
fnp-5269	195	1	hermann bp	PERSON
fnp-5269	195	2	wyler ar	ORG
fnp-5269	195	3	somes g	PERSON
fnp-5269	195	4	dohan fc	PERSON
fnp-5269	198	1	1992;31(4):652-656	CARDINAL
fnp-5269	198	2	656-657	CARDINAL
fnp-5269	200	1	11	CARDINAL
fnp-5269	201	1	wieser hg	PERSON
fnp-5269	202	1	ilae commission	ORG
fnp-5269	205	1	2004;45(6):695-714	CARDINAL
fnp-5269	208	1	wiebe s	PERSON
fnp-5269	208	2	blume wt	PERSON
fnp-5269	208	3	girvin jp	PERSON
fnp-5269	211	1	2001;345(5):311-318	CARDINAL
fnp-5269	213	1	13	CARDINAL
fnp-5269	214	1	pereira dalio mtr	PERSON
fnp-5269	214	2	idf	ORG
fnp-5269	215	1	621	CARDINAL
fnp-5269	216	1	neurol	GPE
fnp-5269	217	1	2022;13:833293	CARDINAL
fnp-5269	218	1	14	CARDINAL
fnp-5269	219	1	wieshmann uc	PERSON
fnp-5269	219	2	larkin d	PERSON
fnp-5269	219	3	varma t	PERSON
fnp-5269	220	1	acta neurol scand	PERSON
fnp-5269	221	1	2008;118(5):306-312	CARDINAL
fnp-5269	223	1	15	CARDINAL
fnp-5269	225	1	10-year	DATE
fnp-5269	225	2	327	CARDINAL
fnp-5269	228	1	2002;4(2):99	CARDINAL
fnp-5269	230	1	16	CARDINAL
fnp-5269	231	1	deleo f	PERSON
fnp-5269	231	2	milesi g	PERSON
fnp-5269	232	1	shortand long-term	PERSON
fnp-5269	234	1	2016;57(2):306	CARDINAL
fnp-5269	236	1	17	CARDINAL
fnp-5269	237	1	janszky j	PERSON
fnp-5269	237	2	janszky	PERSON
fnp-5269	240	1	2005;128(pt 2):395-404	CARDINAL
fnp-5269	241	1	https://doi.org/10.1093/brain/awh358	ORG
fnp-5269	242	1	18	CARDINAL
fnp-5269	242	2	jardim ap	PERSON
fnp-5269	242	3	neves rs da	PERSON
fnp-5269	245	1	2012;70(5):319-324	CARDINAL
fnp-5269	246	1	https://doi.org/10.1590/s0004-282x2012000500003. 19	DATE
fnp-5269	246	2	bielle f	PERSON
fnp-5269	246	3	samson s	PERSON
fnp-5269	249	1	2017;58(8):1473-1485	CARDINAL
fnp-5269	250	1	20	CARDINAL
fnp-5269	251	1	deb p	ORG
fnp-5269	251	2	sharma mc	PERSON
fnp-5269	251	3	tripathi m	PERSON
fnp-5269	251	4	chandra p	PERSON
fnp-5269	251	5	gupta	GPE
fnp-5269	251	6	sarkar c.	PERSON
fnp-5269	253	1	2006;32(5):461-468	CARDINAL
fnp-5269	255	1	giencke k	PERSON
fnp-5269	255	2	wardelmann e	GPE
fnp-5269	256	1	cd34	PRODUCT
fnp-5269	258	1	1999;97(5):481-490	CARDINAL
fnp-5269	260	1	22	CARDINAL
fnp-5269	261	1	giulioni m	PERSON
fnp-5269	261	2	marucci g	PERSON
fnp-5269	266	1	23	CARDINAL
fnp-5269	267	1	marucci g	PERSON
fnp-5269	272	1	24	CARDINAL
fnp-5269	273	1	schindler g	PERSON
fnp-5269	273	2	meyer j	PERSON
fnp-5269	274	1	1,320	CARDINAL
fnp-5269	275	1	acta neuropathol	PERSON
fnp-5269	276	1	2011;121(3):397-405	CARDINAL
fnp-5269	278	1	25	CARDINAL
fnp-5269	279	1	koelsche c	ORG
fnp-5269	281	1	2013;125(6):891	CARDINAL
fnp-5269	283	1	26	CARDINAL
fnp-5269	286	1	2011;122(1):11-19	CARDINAL
fnp-5269	288	1	27	CARDINAL
fnp-5269	289	1	international league	ORG
fnp-5269	290	1	over 29,000	CARDINAL
fnp-5269	290	2	26	CARDINAL
fnp-5269	291	1	nat genet	PERSON
fnp-5269	292	1	2023;55(9):1471-1482	CARDINAL
fnp-5269	293	1	https://doi.org/10.1038/s41588-023-01485-w.	DATE
fnp-5269	294	1	kiuru m	PERSON
fnp-5269	295	1	j am	PERSON
fnp-5269	296	1	2018;79(2):221-229	CARDINAL
fnp-5269	298	1	29	TIME
fnp-5269	299	1	spring kj	PERSON
fnp-5269	299	2	zhao zz	PERSON
fnp-5269	303	1	30	CARDINAL
fnp-5269	303	2	battaglia di	PERSON
fnp-5269	306	1	https://doi.org/10.3390/genes12091316.	DATE
fnp-5269	308	1	goz ru	PERSON
fnp-5269	308	2	loturco	PERSON
fnp-5269	310	1	2020;123(6):2449-2464	DATE
fnp-5269	313	1	koh hy	PERSON
fnp-5269	313	2	kim	PERSON
fnp-5269	313	3	jang j	PERSON
fnp-5269	315	1	nat	ORG
fnp-5269	316	1	2018;24(11):1662	CARDINAL
fnp-5269	318	1	33	CARDINAL
fnp-5269	319	1	bollag g	PERSON
fnp-5269	319	2	tsai j	PERSON
fnp-5269	320	1	raf	ORG
fnp-5269	322	1	2010;467(7315):596	CARDINAL
fnp-5269	323	1	https://doi.org/10.1038/nature09454	ORG
fnp-5269	324	1	34	CARDINAL
fnp-5269	324	2	gogas h	ORG
fnp-5269	324	3	atezolizumab	PERSON
fnp-5269	324	4	vemurafenib	PERSON
fnp-5269	324	5	first	ORDINAL
fnp-5269	324	6	brafv600	GPE
fnp-5269	324	7	3	CARDINAL
fnp-5269	325	1	lancet	ORG
fnp-5269	326	1	2020;395(10240):1835-1844	DATE
fnp-5269	328	1	2024	CARDINAL
fnp-5269	329	1	4.0	CARDINAL
fnp-5269	329	2	https://creativecommons.org/licenses/by/4.0/	WORK_OF_ART